Cavion raises $26.1M series A

Cavion Inc. (Charlottesville, Va.) raised $26.1 million in a series A round co-led by Lilly Ventures and Novartis Venture Fund. Enso Ventures also participated, as did undisclosed existing investors. The company is developing T-type calcium channel modulators to treat neurology and cancer.

Lilly Ventures' Steven Hall, Novartis Venture Fund's Henry Skinner and Enso's Sergei Petukhov have joined the company’s board...